MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
British Journal of Dermatology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

688 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
688 works in the cohort · of 4,299,418page 4 of 14

Labels cover 4 of 688 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 688 of 688 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
The Hidradenitis Suppurativa Priority Setting Partnership
John R Ingram, Rachel Abbott, Mohammad Ghazavi, A.B. Alexandroff, M. McPhee, T. Burton +1 more
2014· article· en· British Journal of Dermatology· Medicine
distilled prediction:candidate · noneconsensus · none
56
citations
affgemma · no categorygpt · no categorymodels agree
Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up)
Jonathan I. Silverberg, Christopher G. Bunick, Hwanhee Hong, Pedro Mendes‐Bastos, Linda Stein Gold, Antonio Costanzo +8 more
2024· article· en· British Journal of Dermatology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
50
citations
afffundunlabeled
Granulocyte–macrophage colony‐stimulating factor ( <scp>GM</scp> ‐ <scp>CSF</scp> ) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐ <scp>GM</scp> ‐ <scp>CSF</scp> monoclonal antibody
Kim Papp, Melinda Gooderham, Richard O. Jenkins, Ronald Vender, Jacek C. Szepietowski, Tristan Wagner +2 more
2018· article· en· British Journal of Dermatology· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+sts+research_integrityconsensus · metaepi_narrow
43
citations
← previousnext →

How this was built: Screen · Findings · About